AVXL
Anavex Life Sciences Corp
NASDAQ: AVXL · HEALTHCARE · BIOTECHNOLOGY
$3.34
+2.45% today
Updated 2026-04-30
Market cap
$309.52M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.46
Dividend yield
—
52W range
$3 – $14
Volume
1.4M
Anavex Life Sciences Corp (AVXL) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | $12495.00 | $25.00 | $7219.00 | $408643.00 | $329849.00 | $203039.00 | $13153.00 | $393449.00 | $7.35M | $15.47M | $9.50M | $27.84M | $24.38M | $25.33M | $34.54M | $161.62M | $152.70M | $154.39M | $135.57M | $103.81M |
| Cash & equivalents | $12275.00 | $25.00 | $6357.00 | $350994.00 | $264669.00 | $134702.00 | $11362.00 | $345074.00 | $7.26M | $15.29M | $9.19M | $27.44M | $22.93M | $22.19M | $29.25M | $152.11M | $149.16M | $151.02M | $132.19M | $102.58M |
| Current assets | $12495.00 | $25.00 | $6357.00 | $406952.00 | $325758.00 | $200605.00 | $12577.00 | $393449.00 | $7.35M | $15.47M | $9.45M | $27.79M | $24.32M | $25.33M | $34.54M | $161.62M | $152.70M | $154.39M | $135.57M | $103.81M |
| Total liabilities | $28006.00 | $462529.00 | $2.30M | $4.27M | $3.29M | $1.35M | $2.89M | $2.86M | $7.16M | $2.66M | $3.19M | $3.58M | $3.88M | $5.04M | $7.31M | $10.80M | $10.21M | $12.53M | $15.30M | $8.95M |
| Current liabilities | $28006.00 | $462529.00 | $2.30M | $4.10M | $3.29M | $1.35M | $2.89M | $1.95M | $1.44M | $2.66M | $3.19M | $3.58M | $3.88M | $5.04M | $7.31M | $10.80M | $10.21M | $12.53M | $15.30M | $8.95M |
| Long-term debt | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $264000.00 | $330.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |
| Shareholder equity | $-15511.00 | $-462504.00 | $-2.29M | $-3.86M | $-2.96M | $-1.14M | $-2.88M | $-2.46M | $192626.00 | $12.81M | $6.31M | $24.25M | $20.49M | $20.29M | $27.24M | $150.82M | $142.49M | $141.85M | $120.26M | $94.87M |
| Retained earnings | $-131552.00 | $-1.71M | $-7.06M | $-12.56M | $-21.90M | $-29.20M | $-37.50M | $-41.20M | $-52.57M | $-63.28M | $-78.02M | $-91.48M | $-108.93M | $-133.40M | $-159.68M | $-197.59M | $-245.56M | $-293.07M | $-336.07M | $-382.45M |
| Accounts receivable | — | — | — | — | $37820.00 | $809.00 | — | — | $76840.00 | $76840.00 | $79347.00 | $9748.00 | $1.87M | $2.64M | $4.85M | $9.14M | $3.19M | $2.71M | $2.45M | $809000.00 |
| Inventory | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $-2.64M | — | $16365.00 | — | — | — | — |
| Goodwill | — | — | — | — | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — | — | — | — | — | — | — |